Wolfram Goessling, M.D., Ph.D., Dana-Farber Cancer Institute (IMAGE)

Dana-Farber Cancer Institute

Wolfram Goessling, M.D., Ph.D., Dana-Farber Cancer Institute

Caption

Wolfram Goessling, M.D., Ph.D., and colleagues demonstrated that an innovative experimental treatment for boosting the effectiveness of stem-cell transplants with umbilical cord blood has a favorable safety profile in long-term animal studies.

Credit

Sam Ogden

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.